GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | September 04, 2024 |
PDB ID | UniProt ID | Title | Descriptor ▲ |
---|---|---|---|
5U7O | Q2N0S5 | Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-626529 in Complex with Human Antibodies PGT122 and 35O22 at 3.8 Angstrom | Envelope glycoprotein gp160, 35O22 FAB HEAVY CHAIN, 35O22 FAB LIGHT CHAIN, PGT122 FAB HEAVY CHAIN, PGT122 FAB LIGHT CHAIN |
5U7O | 5U7O | Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-626529 in Complex with Human Antibodies PGT122 and 35O22 at 3.8 Angstrom | Envelope glycoprotein gp160, 35O22 FAB HEAVY CHAIN, 35O22 FAB LIGHT CHAIN, PGT122 FAB HEAVY CHAIN, PGT122 FAB LIGHT CHAIN |
5U7M | Q2N0S5 | Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-378806 in Complex with Human Antibodies PGT122 and 35O22 at 3.8 Angstrom | Envelope glycoprotein gp160, 35O22 HEAVY CHAIN, 35O22 LIGHT CHAIN, PGT122 HEAVY CHAIN, PGT122 LIGHT CHAIN |
5U7M | 5U7M | Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-378806 in Complex with Human Antibodies PGT122 and 35O22 at 3.8 Angstrom | Envelope glycoprotein gp160, 35O22 HEAVY CHAIN, 35O22 LIGHT CHAIN, PGT122 HEAVY CHAIN, PGT122 LIGHT CHAIN |
6CH7 | Q2N0S7 | XFEL crystal structure of a natively-glycosylated BG505 SOSIP.664 HIV-1 Envelope Trimer in complex with the broadly-neutralizing antibodies BG18 and 35O22 | Envelope glycoprotein gp160, 35O22 Heavy Chain, 35O22 Light Chain, BG18 Heavy Chain, BG18 Light Chain |
6CH7 | 6CH7 | XFEL crystal structure of a natively-glycosylated BG505 SOSIP.664 HIV-1 Envelope Trimer in complex with the broadly-neutralizing antibodies BG18 and 35O22 | Envelope glycoprotein gp160, 35O22 Heavy Chain, 35O22 Light Chain, BG18 Heavy Chain, BG18 Light Chain |
6CH7 | Q2N0S6 | XFEL crystal structure of a natively-glycosylated BG505 SOSIP.664 HIV-1 Envelope Trimer in complex with the broadly-neutralizing antibodies BG18 and 35O22 | Envelope glycoprotein gp160, 35O22 Heavy Chain, 35O22 Light Chain, BG18 Heavy Chain, BG18 Light Chain |
6MU6 | Q2N0S6 | Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-814508 in Complex with Human Antibodies 3H109L and 35O22 at 3.2 Angstrom | Envelope glycoprotein gp160, 35O22 scFv heavy chain portion, 35O22 scFv light chain portion, 3H109L Fab heavy chain, 3H109L Fab light chain |
6MU6 | 6MU6 | Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-814508 in Complex with Human Antibodies 3H109L and 35O22 at 3.2 Angstrom | Envelope glycoprotein gp160, 35O22 scFv heavy chain portion, 35O22 scFv light chain portion, 3H109L Fab heavy chain, 3H109L Fab light chain |
6MUF | B3UEZ6 | Crystal Structure of HIV-1 B41 SOSIP.664 Prefusion Env Trimer in Complex with Human Antibodies 3H109L and 35O22 at 3.4 Angstrom | Envelope glycoprotein gp160, 35O22 scFv heavy chain portion, 35O22 scFv light chain portion, 3H109L Fab heavy chain, 3H109L Fab light chain |
6MUF | 6MUF | Crystal Structure of HIV-1 B41 SOSIP.664 Prefusion Env Trimer in Complex with Human Antibodies 3H109L and 35O22 at 3.4 Angstrom | Envelope glycoprotein gp160, 35O22 scFv heavy chain portion, 35O22 scFv light chain portion, 3H109L Fab heavy chain, 3H109L Fab light chain |
6MUF | B3UES2 | Crystal Structure of HIV-1 B41 SOSIP.664 Prefusion Env Trimer in Complex with Human Antibodies 3H109L and 35O22 at 3.4 Angstrom | Envelope glycoprotein gp160, 35O22 scFv heavy chain portion, 35O22 scFv light chain portion, 3H109L Fab heavy chain, 3H109L Fab light chain |
6MTJ | Q2N0S6 | Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-378806 in Complex with Human Antibodies 3H109L and 35O22 at 2.9 Angstrom | Envelope glycoprotein gp160, 35O22 scFv heavy chain portion, 35O22 scFv light chain portion, 3H109L Fab heavy chain, 3H109L Fab light chain |
6MTJ | 6MTJ | Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-378806 in Complex with Human Antibodies 3H109L and 35O22 at 2.9 Angstrom | Envelope glycoprotein gp160, 35O22 scFv heavy chain portion, 35O22 scFv light chain portion, 3H109L Fab heavy chain, 3H109L Fab light chain |
6MTN | Q2N0S6 | Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor Compound 484 in Complex with Human Antibodies 3H109L and 35O22 at 3.0 Angstrom | Envelope glycoprotein gp160, 35O22 scFv heavy chain portion, 35O22 scFv light chain portion, 3H109L Fab heavy chain, 3H109L Fab light chain |
6MTN | 6MTN | Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor Compound 484 in Complex with Human Antibodies 3H109L and 35O22 at 3.0 Angstrom | Envelope glycoprotein gp160, 35O22 scFv heavy chain portion, 35O22 scFv light chain portion, 3H109L Fab heavy chain, 3H109L Fab light chain |
6MU8 | Q2N0S6 | Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-386150 in Complex with Human Antibodies 3H109L and 35O22 at 3.5 Angstrom | Envelope glycoprotein gp160, 35O22 scFv heavy chain portion, 35O22 scFv light chain portion, 3H109L Fab heavy chain, 3H109L Fab light chain |
6MU8 | 6MU8 | Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-386150 in Complex with Human Antibodies 3H109L and 35O22 at 3.5 Angstrom | Envelope glycoprotein gp160, 35O22 scFv heavy chain portion, 35O22 scFv light chain portion, 3H109L Fab heavy chain, 3H109L Fab light chain |
6MU7 | Q2N0S6 | Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-818251 in Complex with Human Antibodies 3H109L and 35O22 at 3.1 Angstrom | Envelope glycoprotein gp160, 35O22 scFv heavy chain portion, 35O22 scFv light chain portion, 3H109L Fab heavy chain, 3H109L Fab light chain |
6MU7 | 6MU7 | Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-818251 in Complex with Human Antibodies 3H109L and 35O22 at 3.1 Angstrom | Envelope glycoprotein gp160, 35O22 scFv heavy chain portion, 35O22 scFv light chain portion, 3H109L Fab heavy chain, 3H109L Fab light chain |
6MUG | B3UEZ6 | Crystal Structure of HIV-1 B41 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-386150 in Complex with Human Antibodies 3H109L and 35O22 at 3.8 Angstrom | Envelope glycoprotein gp160, 35O22 scFv heavy chain portion, 35O22 scFv light chain portion, 3H109L Fab heavy chain, 3H109L Fab light chain |
6MUG | 6MUG | Crystal Structure of HIV-1 B41 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-386150 in Complex with Human Antibodies 3H109L and 35O22 at 3.8 Angstrom | Envelope glycoprotein gp160, 35O22 scFv heavy chain portion, 35O22 scFv light chain portion, 3H109L Fab heavy chain, 3H109L Fab light chain |
6MUG | B3UES2 | Crystal Structure of HIV-1 B41 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-386150 in Complex with Human Antibodies 3H109L and 35O22 at 3.8 Angstrom | Envelope glycoprotein gp160, 35O22 scFv heavy chain portion, 35O22 scFv light chain portion, 3H109L Fab heavy chain, 3H109L Fab light chain |
5VIY | Q2N0S6 | BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 | Envelope glycoprotein gp160, BG1 Fab light chain,BG1 Fab light chain, BG1 Fab heavy chain,BG1 Fab heavy chain, 8ANC195 G52K5 Fab heavy chain,8ANC195 G52K5 Fab heavy chain, 8ANC195 G52K5 Fab light chain,8ANC195 G52K5 Fab light chain |
5VIY | P01834 | BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 | Envelope glycoprotein gp160, BG1 Fab light chain,BG1 Fab light chain, BG1 Fab heavy chain,BG1 Fab heavy chain, 8ANC195 G52K5 Fab heavy chain,8ANC195 G52K5 Fab heavy chain, 8ANC195 G52K5 Fab light chain,8ANC195 G52K5 Fab light chain |
5VIY | 5VIY | BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 | Envelope glycoprotein gp160, BG1 Fab light chain,BG1 Fab light chain, BG1 Fab heavy chain,BG1 Fab heavy chain, 8ANC195 G52K5 Fab heavy chain,8ANC195 G52K5 Fab heavy chain, 8ANC195 G52K5 Fab light chain,8ANC195 G52K5 Fab light chain |
5VIY | P01834 | BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 | Envelope glycoprotein gp160, BG1 Fab light chain,BG1 Fab light chain, BG1 Fab heavy chain,BG1 Fab heavy chain, 8ANC195 G52K5 Fab heavy chain,8ANC195 G52K5 Fab heavy chain, 8ANC195 G52K5 Fab light chain,8ANC195 G52K5 Fab light chain |
5VIY | 5VIY | BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 | Envelope glycoprotein gp160, BG1 Fab light chain,BG1 Fab light chain, BG1 Fab heavy chain,BG1 Fab heavy chain, 8ANC195 G52K5 Fab heavy chain,8ANC195 G52K5 Fab heavy chain, 8ANC195 G52K5 Fab light chain,8ANC195 G52K5 Fab light chain |
5VIY | S6B291 | BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 | Envelope glycoprotein gp160, BG1 Fab light chain,BG1 Fab light chain, BG1 Fab heavy chain,BG1 Fab heavy chain, 8ANC195 G52K5 Fab heavy chain,8ANC195 G52K5 Fab heavy chain, 8ANC195 G52K5 Fab light chain,8ANC195 G52K5 Fab light chain |
5VIY | S6B291 | BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 | Envelope glycoprotein gp160, BG1 Fab light chain,BG1 Fab light chain, BG1 Fab heavy chain,BG1 Fab heavy chain, 8ANC195 G52K5 Fab heavy chain,8ANC195 G52K5 Fab heavy chain, 8ANC195 G52K5 Fab light chain,8ANC195 G52K5 Fab light chain |
5VIY | Q8TCD0 | BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 | Envelope glycoprotein gp160, BG1 Fab light chain,BG1 Fab light chain, BG1 Fab heavy chain,BG1 Fab heavy chain, 8ANC195 G52K5 Fab heavy chain,8ANC195 G52K5 Fab heavy chain, 8ANC195 G52K5 Fab light chain,8ANC195 G52K5 Fab light chain |
5VIY | Q8TCD0 | BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 | Envelope glycoprotein gp160, BG1 Fab light chain,BG1 Fab light chain, BG1 Fab heavy chain,BG1 Fab heavy chain, 8ANC195 G52K5 Fab heavy chain,8ANC195 G52K5 Fab heavy chain, 8ANC195 G52K5 Fab light chain,8ANC195 G52K5 Fab light chain |
6VKN | Q2N0S6 | BG505 SOSIP.v5.2.N241.N289 in complex with rhesus macaque Fab RM19R | Envelope glycoprotein gp160, BG505 SOSIPv5.2 gp41, RM19R Kappa Light Chain, RM19R Heavy Chain |
6VKN | 6VKN | BG505 SOSIP.v5.2.N241.N289 in complex with rhesus macaque Fab RM19R | Envelope glycoprotein gp160, BG505 SOSIPv5.2 gp41, RM19R Kappa Light Chain, RM19R Heavy Chain |
6VN0 | Q2N0S6 | BG505 SOSIP.v4.1 in complex with rhesus macaque Fab RM20F | Envelope glycoprotein gp160, BG505 SOSIPv5.2 gp41, RM19R Kappa Light Chain, RM19R Heavy Chain |
6VN0 | 6VN0 | BG505 SOSIP.v4.1 in complex with rhesus macaque Fab RM20F | Envelope glycoprotein gp160, BG505 SOSIPv5.2 gp41, RM19R Kappa Light Chain, RM19R Heavy Chain |
6OZC | Q2N0S6 | BG505 SOSIP.664 with 2G12 Fab2 | Envelope glycoprotein gp160, Envelope glycoprotein gp41, 2G12 Fab light chain, 2G12 Fab Heavy chain |
6OZC | 6OZC | BG505 SOSIP.664 with 2G12 Fab2 | Envelope glycoprotein gp160, Envelope glycoprotein gp41, 2G12 Fab light chain, 2G12 Fab Heavy chain |
6OPN | B3UES2 | CD4- and 17-bound HIV-1 Env B41 SOSIP in complex with small molecule GO35 | Envelope glycoprotein gp160, Envelope glycoprotein gp41, T-cell surface glycoprotein CD4 |
6OPN | B3UEZ6 | CD4- and 17-bound HIV-1 Env B41 SOSIP in complex with small molecule GO35 | Envelope glycoprotein gp160, Envelope glycoprotein gp41, T-cell surface glycoprotein CD4 |
6OPN | P01730 | CD4- and 17-bound HIV-1 Env B41 SOSIP in complex with small molecule GO35 | Envelope glycoprotein gp160, Envelope glycoprotein gp41, T-cell surface glycoprotein CD4 |
6DCQ | A0A2H4K974 | Ectodomain of full length, wild type HIV-1 glycoprotein clone PC64M18C043 in complex with PGT151 Fab | Envelope glycoprotein gp160, Immunoglobulin G PGT151 Fab, Heavy chain, Immunoglobulin G PGT151 Fab, Light chain |
6DCQ | S6B291 | Ectodomain of full length, wild type HIV-1 glycoprotein clone PC64M18C043 in complex with PGT151 Fab | Envelope glycoprotein gp160, Immunoglobulin G PGT151 Fab, Heavy chain, Immunoglobulin G PGT151 Fab, Light chain |
6DCQ | 6DCQ | Ectodomain of full length, wild type HIV-1 glycoprotein clone PC64M18C043 in complex with PGT151 Fab | Envelope glycoprotein gp160, Immunoglobulin G PGT151 Fab, Heavy chain, Immunoglobulin G PGT151 Fab, Light chain |
6DCQ | S6B291 | Ectodomain of full length, wild type HIV-1 glycoprotein clone PC64M18C043 in complex with PGT151 Fab | Envelope glycoprotein gp160, Immunoglobulin G PGT151 Fab, Heavy chain, Immunoglobulin G PGT151 Fab, Light chain |
6DCQ | 6DCQ | Ectodomain of full length, wild type HIV-1 glycoprotein clone PC64M18C043 in complex with PGT151 Fab | Envelope glycoprotein gp160, Immunoglobulin G PGT151 Fab, Heavy chain, Immunoglobulin G PGT151 Fab, Light chain |
6DCQ | Q8TCD0 | Ectodomain of full length, wild type HIV-1 glycoprotein clone PC64M18C043 in complex with PGT151 Fab | Envelope glycoprotein gp160, Immunoglobulin G PGT151 Fab, Heavy chain, Immunoglobulin G PGT151 Fab, Light chain |
6DCQ | Q8TCD0 | Ectodomain of full length, wild type HIV-1 glycoprotein clone PC64M18C043 in complex with PGT151 Fab | Envelope glycoprotein gp160, Immunoglobulin G PGT151 Fab, Heavy chain, Immunoglobulin G PGT151 Fab, Light chain |
6SNE | 6SNE | crystal structure of LN01 Fab in complex with an HIV-1 gp41 peptide | Envelope glycoprotein gp160, LN01 light chain, LN01 heavy chain |
6SNE | Q74599 | crystal structure of LN01 Fab in complex with an HIV-1 gp41 peptide | Envelope glycoprotein gp160, LN01 light chain, LN01 heavy chain |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024